WO2025008784 - SOLID DISPERSIONS OF TAPINAROF AND A PROCESS FOR THE PREPARATION THEREOF

National phase entry is expected:
Publication Number WO/2025/008784
Publication Date 09.01.2025
International Application No. PCT/IB2024/056540
International Filing Date 04.07.2024
Title **
[English] SOLID DISPERSIONS OF TAPINAROF AND A PROCESS FOR THE PREPARATION THEREOF
[French] DISPERSIONS SOLIDES DE TAPINAROF ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
ALIVUS LIFE SCIENCES LIMITED Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth Solapur 413213, IN
Inventors
PALLE, Venkata Raghavendra Acharyulu Bungalow 24, Gera Green Ville, Survey no. 64, Grant Road, Kharadi, Maharashtra Pune 411014, IN
KADAM, Suresh 1501, B-wing, Royal Bldg., Neelkanth Palms Co-op. Hsg. Society, Kapurbawdi Thane (West), Maharashtra Thane 400610, IN
GAVHANE, Sachin Platina E1306 Casa Bella Gold Palava, Dombivli (East), Kalyan Shil Road Maharashtra Thane 421204, IN
DABE, Avikumar B-301, Lenyadri park, Near Don Bosco School, Kalyan west, Maharashtra Kalyan 421301, IN
KAWADE, Sagar Flat No 504, Building No-25, Riverwood Park, Khidkali, Kalyan-shil Road, Dombivali (E), Maharashtra Thane 421204, IN
Priority Data
202321044893   04.07.2023   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1160
EPO Filing, Examination6999
Japan Filing587
South Korea Filing574
USA Filing, Examination3910
MasterCard Visa

Total: 13230

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to a solid dispersion comprising tapinarof or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. The present invention also relates to a process for the preparation of the solid dispersion, a pharmaceutical composition comprising the solid dispersion, and use of the solid dispersion or the pharmaceutical composition in the treatment of chronic inflammatory skin diseases.[French] La présente invention concerne une dispersion solide comprenant du tapinarof ou un sel pharmaceutiquement acceptable de celui-ci, et un excipient pharmaceutiquement acceptable. La présente invention concerne également un procédé de préparation de la dispersion solide, une composition pharmaceutique comprenant la dispersion solide, et l'utilisation de la dispersion solide ou de la composition pharmaceutique dans le traitement de maladies cutanées inflammatoires chroniques.
An unhandled error has occurred. Reload 🗙